Kwong Lung Enterprise Co., Ltd. carries a market capitalization of 6.54B, placing it among publicly traded companies globally. Its enterprise value stands at 9.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 6.54B |
| Enterprise Value | 9.23B |
Kwong Lung Enterprise Co., Ltd. currently has 150.20M shares outstanding.
| Shares Outstanding | 150.20M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Kwong Lung Enterprise Co., Ltd. trades at a trailing price-to-earnings ratio of 45.21. The price-to-sales ratio is 1.18, and the price-to-book ratio stands at 2.86.
| PE Ratio | 45.21 |
| PS Ratio | 1.18 |
| PB Ratio | 2.86 |
| P/TBV Ratio | 1.40 |
| P/FCF Ratio | 10.55 |
| P/OCF Ratio | 13.36 |
On an enterprise value basis, Kwong Lung Enterprise Co., Ltd. trades at an EV/EBITDA multiple of 30.23 and an EV/FCF ratio of 12.42. The EV/Sales ratio of 1.45 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 30.23 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.45 |
| EV / EBITDA | 30.23 |
| EV / EBIT | 30.23 |
| EV / FCF | 12.42 |
Kwong Lung Enterprise Co., Ltd. maintains a current ratio of 1.18, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 55.64, indicating elevated leverage, while an interest coverage ratio of 8.19 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.18 |
| Quick Ratio | 0.38 |
| Debt / Equity | 55.64 |
| Debt / EBITDA | 9.83 |
| Interest Coverage | 8.19 |
Kwong Lung Enterprise Co., Ltd. posts a return on equity of 6.20 and a return on invested capital of 2.70.
| Return on Equity (ROE) | 6.20 |
| Return on Assets (ROA) | 1.66 |
| Return on Invested Capital (ROIC) | 2.70 |
| Return on Capital Employed (ROCE) | 3.55 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.68 |
Over the trailing twelve months, Kwong Lung Enterprise Co., Ltd. has paid 55.55M in income taxes, reflecting an effective tax rate of 25.04.
| Income Tax | 55.55M |
| Effective Tax Rate | 25.04 |
Kwong Lung Enterprise Co., Ltd.'s stock has declined approximately -12.87129% over the past 52 weeks. The 50-day moving average sits at 45.54, while the 200-day moving average is 47.85.
| Beta (5Y) | N/A |
| 52-Week Price Change | -12.87129% |
| 50-Day Moving Average | 45.54 |
| 200-Day Moving Average | 47.85 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Kwong Lung Enterprise Co., Ltd. generated 6.37B in revenue and converted that into 166.40M in net income, yielding earnings per share of 1.10. EBITDA reached 305.45M, while operating income came in at 305.45M.
| Revenue | 6.37B |
| Gross Profit | 905.82M |
| Operating Income | 305.45M |
| Pretax Income | 221.85M |
| Net Income | 166.40M |
| EBITDA | 305.45M |
| EBIT | 305.45M |
| Earnings Per Share (EPS) | 1.10 |
Kwong Lung Enterprise Co., Ltd. holds 1.31B in cash and equivalents against 3.00B in total debt, resulting in a net debt position of 2.07B. Total book value stands at 2.63B, with working capital of 616.65M providing operational flexibility.
| Cash & Cash Equivalents | 1.31B |
| Total Debt | 3.00B |
| Net Debt | 2.07B |
| Equity (Book Value) | 2.63B |
| Book Value Per Share | 17.40 |
| Working Capital | 616.65M |
Kwong Lung Enterprise Co., Ltd. produced 563.31M in operating cash flow over the past twelve months. After subtracting -152.05M in capital expenditures, free cash flow totaled 411.27M - equivalent to 2.72 per share.
| Operating Cash Flow | 563.31M |
| Capital Expenditures | -152.05M |
| Free Cash Flow | 411.27M |
| FCF Per Share | 2.72 |
Kwong Lung Enterprise Co., Ltd. operates with a gross margin of 14.21, reflecting its pricing power and cost economics. The operating margin of 4.79 and net profit margin of 2.61 provide insight into operational efficiency.
| Gross Margin | 14.21 |
| Operating Margin | 4.79 |
| Pretax Margin | 3.48 |
| Profit Margin | 2.61 |
| EBITDA Margin | 4.79 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -3.13 |
| FCF Yield | 9.48 |
Kwong Lung Enterprise Co., Ltd.'s most recent stock split took place on July 24, 2014 with a 50:51 split ratio.
| Last Split Date | 7/24/2014 |
| Split Ratio | 50:51 |
Kwong Lung Enterprise Co., Ltd. posts an Altman Z-Score of 2.02, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.02 |